Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$60.15 - $84.52 $15.6 Million - $21.9 Million
-258,937 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$75.08 - $121.99 $33.1 Million - $53.8 Million
-441,063 Reduced 63.01%
258,937 $19.4 Million
Q2 2021

Aug 16, 2021

BUY
$130.4 - $225.58 $26.1 Million - $45.1 Million
200,000 Added 40.0%
700,000 $155 Million
Q1 2021

May 17, 2021

SELL
$124.11 - $190.17 $31 Million - $47.5 Million
-250,000 Reduced 33.33%
500,000 $66.1 Million
Q4 2020

Feb 16, 2021

SELL
$112.16 - $174.14 $64.5 Million - $100 Million
-575,000 Reduced 43.4%
750,000 $130 Million
Q3 2020

Nov 16, 2020

SELL
$58.05 - $111.31 $21.8 Million - $41.7 Million
-375,000 Reduced 22.06%
1,325,000 $147 Million
Q2 2020

Aug 14, 2020

BUY
$57.2 - $74.41 $20 Million - $26 Million
350,000 Added 25.93%
1,700,000 $101 Million
Q4 2019

Feb 14, 2020

BUY
$68.3 - $93.8 $23.9 Million - $32.8 Million
350,000 Added 35.0%
1,350,000 $114 Million
Q3 2019

Nov 14, 2019

SELL
$61.86 - $97.8 $30.9 Million - $48.9 Million
-500,000 Reduced 33.33%
1,000,000 $74.8 Million
Q2 2019

Aug 14, 2019

SELL
$42.22 - $63.23 $10.6 Million - $15.8 Million
-250,000 Reduced 14.29%
1,500,000 $94.8 Million
Q1 2019

May 15, 2019

SELL
$31.96 - $56.12 $12.8 Million - $22.4 Million
-400,000 Reduced 18.6%
1,750,000 $84.3 Million
Q4 2018

Feb 14, 2019

BUY
$28.72 - $52.63 $38.1 Million - $69.7 Million
1,325,089 Added 160.63%
2,150,000 $72 Million
Q3 2018

Nov 14, 2018

BUY
$32.0 - $52.4 $26.4 Million - $43.2 Million
824,911 New
824,911 $43.2 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.88B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Darsana Capital Partners LP Portfolio

Follow Darsana Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darsana Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Darsana Capital Partners LP with notifications on news.